Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 1999 Aug;67(2):195-8.
doi: 10.1136/jnnp.67.2.195.

Mutations producing premature termination of translation and an amino acid substitution in the sterol 27-hydroxylase gene cause cerebrotendinous xanthomatosis associated with parkinsonism

Affiliations
Case Reports

Mutations producing premature termination of translation and an amino acid substitution in the sterol 27-hydroxylase gene cause cerebrotendinous xanthomatosis associated with parkinsonism

N Wakamatsu et al. J Neurol Neurosurg Psychiatry. 1999 Aug.

Abstract

Objectives: Mutational analysis of the sterol 27-hydroxylase (CYP27) gene was performed on three patients from two Japanese families who had cerebrotendinous xanthomatosis (CTX) associated with parkinsonism.

Methods: Clinical evaluations, brain MRI studies, and laboratory analyses were completed on the three patients. The CYP27 gene was analysed for mutations by PCR amplification of gene segments followed by direct sequencing.

Results: Two different, homozygous mutations were identified in these families. One is a novel transition, substituting T for G at Glu162 (GAG) resulting in a stop codon (TAG). The other is also a transition, substituting T for C at Arg441 (CGG) resulting in Trp (TGG). The second is located in two amino acids ahead of the heme ligand binding site (Cys443) of the protein likely rendering it non-functional. It is the most common CTX mutation in Japanese patients.

Conclusions: CTX with parkinsonism is caused by mutations with a severe impact on enzyme function. The two mutations described here are likely to cause loss of function because they are chain terminating or affect an essential site in the protein.

PubMed Disclaimer

Similar articles

Cited by

References

    1. N Engl J Med. 1984 Dec 27;311(26):1649-52 - PubMed
    1. J Lipid Res. 1998 Mar;39(3):509-17 - PubMed
    1. J Biol Chem. 1991 Apr 25;266(12):7774-8 - PubMed
    1. J Biol Chem. 1991 Apr 25;266(12):7779-83 - PubMed
    1. J Neurol Sci. 1991 Apr;102(2):225-32 - PubMed

Publication types

MeSH terms

Substances